Stock listing

NASDAQ:BIIB Biogen Inc. Stock

Home listing (NASDAQ) of Biogen Inc.

Follow Biogen Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:BIIB

$232.65 USD -2.70 (-1.1%)

Close on Oct 16, 2026

Biogen Inc. logo
Ticker
NASDAQ:BIIB
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Upcoming

  • Biogen (NASDAQ:BIIB) Q3 2026 Earnings Call

    Wed, Oct 28, 2026 · 8:30 AM ET

    Register

Replays

  • Biogen (NASDAQ:BIIB) Q2 2026 Earnings Call

    Wed, Jul 29, 2026 · 8:30 AM ET

    Watch Transcript

  • Biogen (NASDAQ:BIIB) Q1 2026 Earnings Call

    Wed, Apr 29, 2026 · 8:00 AM ET

    Watch Transcript

  • Biogen (NASDAQ:BIIB) Q4 2025 Earnings Call

    Fri, Feb 06, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus

Oct 2, 2026

Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN

Sep 17, 2026

LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer’s Disease

Sep 16, 2026

LEQEMBI® (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer’s Disease Approved in China

Sep 3, 2026

Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease

Aug 31, 2026

Veeva Vault CRM Selected by Biogen

Aug 25, 2026

Issued by another party

LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease

Aug 24, 2026

Biogen Completes Acquisition of RayThera Inc.

Aug 6, 2026

Biogen Reports Second Quarter 2026 Results

Jul 29, 2026

Synapticure Launches Groundbreaking Ataxia Care Program, Expanding Access to Specialized Neurology Nationwide

Jul 16, 2026

Issued by another party

All Biogen Inc. news

Decks

Biogen Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
78 in the last 12 months · 239 in all · newest Oct 2, 2026 · oldest 2021
Calls
26 calls with a replay · 26 with a transcript · latest Jul 29, 2026
Decks
49 decks · latest Jul 29, 2026

Where Biogen Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:BIIB · Home listing · This pageNASDAQUnited StatesUSD
gettex:IDPgettexGermanyEUR
BCBA:BIIBBCBAArgentinaARS
Tradegate:IDPTradegateGermanyEUR
LS Exchange:789617LS ExchangeGermanyEUR
BMV:BIIBBMVMexicoMXN
BCBA:BIIBDBCBAArgentinaUSD
Lang & Schwarz:789617Lang & SchwarzGermanyEUR
BCS:BIIBBCSChileUSD
LSE:0R1BLSEUnited KingdomUSD
Frankfurt:IDPFrankfurtGermanyEUR
Milan:1BIIBMilanItalyEUR
B3:BIIB34B3BrazilBRL
BOATS:BIIBBOATSUnited StatesUSD
Stuttgart:IDPStuttgartGermanyEUR
BIVA:BIIBBIVAMexicoMXN
Hamburg:IDPHamburgGermanyEUR
SIX Swiss:BIIB.USDSIX SwissSwitzerlandUSD
Munich:IDPMunichGermanyEUR
VIE:BIIBViennaAustriaEUR
Dusseldorf:IDPDusseldorfGermanyEUR
Hanover:IDPHanoverGermanyEUR
SIX Swiss:BIIBSIX SwissSwitzerlandCHF
BCS:BIIBCLBCSChileCLP
Turquoise:BIIBNTurquoiseUnited KingdomUSD
BCBA:BIIBCBCBAArgentinaUSD
EUROTLX:4BIIBEUROTLXItalyEUR
BX Swiss:IDPBX SwissSwitzerlandCHF
BCBA:BIIB.CIBCBAArgentinaARS
Xetra:IDPXetraGermanyEUR

Log in to ask 6ix AI your own questions about Biogen Inc.